Systemic inflammation and reduced pulmonary function in chronic spinal cord injury

PM and R

Volumn 3, Issue 5, 2011, Pages 433-439

  Garshick, Eric ^a,b,c   Stolzmann, Kelly L ^c   Gagnon, David R ^a,d   Morse, Leslie R ^c,e   Brown, Robert ^c,f  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; SMOKING; SPINAL CORD INJURY;

ADULT; AGED; C-REACTIVE PROTEIN; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INTERLEUKIN-6; LUNG; MALE; MIDDLE AGED; PARAPLEGIA; SPINAL CORD INJURIES; VITAL CAPACITY;

EID: 79955821688     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2011.02.003     Document Type: Article

References (44)

1. Spungen A.M., Adkins R.H., Stewart C.A., et al. Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol 2003, 95:2398-2407.
2. Maggioni M., Bertoli S., Margonato V., et al. Body composition assessment in spinal cord injury subjects. Acta Diabetol 2003, 40(Suppl 1):S183-S186.
3. Jones L.M., Legge M., Goulding A. Healthy body mass index values often underestimate body fat in men with spinal cord injury. Arch Phys Med Rehabil 2003, 84:1068-1071.
4. Frost F., Roach M.J., Kushner I., et al. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil 2005, 86:312-317.
5. Segal J.L., Gonzales E., Yousefi S., et al. Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Arch Phys Med Rehabil 1997, 78:44-47.
6. Manns P.J., McCubbin J.A., Williams D.P. Fitness, inflammation, and the metabolic syndrome in men with paraplegia. Arch Phys Med Rehabil 2005, 86:1176-1181.
7. Nelson M.D., Widman L.M., Abresch R.T., et al. Metabolic syndrome in adolescents with spinal cord dysfunction. J Spinal Cord Med 2007, 30(Suppl 1):S127-S139.
8. Myers J., Lee M., Kiratli J. Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management. Am J Phys Med Rehabil 2007, 86:142-152.
9. Mannino D.M., Ford E.S., Redd S.C. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003, 114:758-762.
10. Gan W.Q., Man S.F., Senthilselvan A., et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
11. Man S.F., Connett J.E., Anthonisen N.R., et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853.
12. Eagan T.M., Ueland T., Wagner P.D., et al. Systemic inflammatory markers in chronic obstructive pulmonary disease: results from the Bergen COPD Cohort Study. Eur Respir J 2010, 35:540-548.
13. Kony S., Zureik M., Driss F., et al. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 2004, 59:892-896.
14. Tomiyama H., Okazaki R., Koji Y., et al. Elevated C-reactive protein: a common marker for atherosclerotic cardiovascular risk and subclinical stages of pulmonary dysfunction and osteopenia in a healthy population. Atherosclerosis 2005, 178:187-192.
15. Yende S., Waterer G.W., Tolley E.A., et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006, 61:10-16.
16. Shaaban R., Kony S., Driss F., et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med 2006, 100:2112-2120.
17. Melbye H., Halvorsen D.S., Hartz I., et al. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromso Study 2001. Respir Med 2007, 101:2541-2549.
18. Fogarty A.W., Jones S., Britton J.R., et al. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007, 62:515-520.
19. Thorleifsson S.J., Margretardottir O.B., Gudmundsson G., et al. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med 2009, 103:1548-1553.
20. Walter R.E., Wilk J.B., Larson M.G., et al. Systemic Inflammation and COPD: the Framingham Heart Study. Chest 2008, 133:19-25.
21. Aronson D., Roterman I., Yigla M., et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 2006, 174:626-632.
22. Hancox R.J., Poulton R., Greene J.M., et al. Systemic inflammation and lung function in young adults. Thorax 2007, 62:1064-1068.
23. Rasmussen F., Mikkelsen D., Hancox R.J., et al. High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J 2009, 33:382-388.
24. Jain N.B., Brown R., Tun C.G., et al. Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury. Arch Phys Med Rehabil 2006, 87:1327-1333.
25. Stolzmann K.S., Gagnon D.G., Brown R., et al. Determinants of longitudinal change in FEV1 and FVC in spinal cord injury. Am J Respir Crit Care Med 2008, 177:781-786.
26. Morse L.R., Stolzmann K., Nguyen H.P., et al. Association between mobility mode and C-reactive protein levels in men with chronic spinal cord injury. Arch Phys Med Rehabil 2008, 89:726-731.
27. Marino R.J., Barros T., Biering-Sorenson F., et al. International standards for neurological classification of spinal cord injury. J Spinal Cord Injury Med 2003, 26:550-556.
28. Ferris B.G. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978, 118:1-120.
29. Garshick E., Kelley A., Cohen S.A., et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord 2005, 43:408-416.
30. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
31. Kelley A., Garshick E., Gross E.R., et al. Spirometry testing standards in spinal cord injury. Chest 2003, 123:725-730.
32. Garshick E., Ashba J., Tun C.G., et al. Assessment of stature in spinal cord injury. J Spinal Cord Med 1997, 20:36-42.
33. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
34. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001, 47:426-430.
35. Miles M.P., Andring J.M., Pearson S.D., et al. Diurnal variation, response to eccentric exercise, and association of inflammatory mediators with muscle damage variables. J Appl Physiol 2008, 104:451-458.
36. Shore S.A., Fredberg J.J. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol 2005, 115:925-927.
37. Weiss S.T., Shore S. Obesity and asthma: directions for research. Am J Respir Crit Care Med 2004, 169:963-968.
38. Yeatts K., Sly P., Shore S., et al. A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research. Environ Health Perspect 2006, 114:634-640.
39. Alexeeff S.E., Litonjua A.A., Sparrow D., et al. Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 2007, 176:742-747.
40. Garcia-Aymerich J., Lange P., Benet M., et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007, 175:458-463.
41. Wang T.D., Wang Y.H., Huang T.S., et al. Circulating levels of markers of inflammation and endothelial activation are increased in men with chronic spinal cord injury. J Formos Med Assoc 2007, 106:919-928.
42. Kasapis C., Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45:1563-1569.
43. Nicklas B.J., You T., Pahor M. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Can Med Assoc J 2005, 172:1199-1209.
44. Fischer C.P., Berntsen A., Perstrup L.B., et al. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 2007, 17:580-587.